» Articles » PMID: 24355599

Selective Distribution and Dynamic Modulation of MiRNAs in the Synapse and Its Possible Role in Alzheimer's Disease

Overview
Journal Brain Res
Specialty Neurology
Date 2013 Dec 21
PMID 24355599
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRNAs) are small non-coding RNAs that control a wide range of functions in the cell. They act as post-transcriptional gene regulators throughout in development and in adulthood, although recent evidence suggests their potential role in the onset and development of various diseases and neuropathologies. In neurons miRNAs seem to play a key role as regulators of synaptic function. Synapses are vulnerable structures in neurodegenerative diseases. In particular, synaptic loss has been described as an early event in the pathogenesis of Alzheimer's Disease (AD). MicroRNA-mediated gene silencing represents a candidate event for the repression of specific mRNAs and protein synthesis that could account for synaptic dysfunction. In this work, we review the participation of miRNAs in synaptic function and consider their possible role in synaptic alterations in AD. First we review the biogenesis of miRNAs and their role as post-transcriptional regulators. Then we discuss recently published data on the distribution of miRNAs in the brain as well as their role in dynamic regulation at the synapse. In the second part, we briefly introduce the reader to AD, focusing on synaptic alterations in the progression of the pathology. Then we discuss possible implications of miRNAs in the associated synaptic dysfunction.

Citing Articles

MicroRNAs as Diagnostic Biomarkers and Predictors of Antidepressant Response in Major Depressive Disorder: A Systematic Review.

Carneiro B, Franco Guerreiro-Costa L, Lins-Silva D, Faria Guimaraes D, Souza L, Leal G Cureus. 2024; 16(3):e56910.

PMID: 38665721 PMC: 11043793. DOI: 10.7759/cureus.56910.


The Association Between Circulating Klotho and Dipeptidyl Peptidase-4 Activity and Inflammatory Cytokines in Elderly Patients With Alzheimer Disease.

Sedighi M, Baluchnejadmojarad T, Fallah S, Moradi N, Afshin-Majd S, Roghani M Basic Clin Neurosci. 2020; 11(3):349-357.

PMID: 32963727 PMC: 7502192. DOI: 10.32598/bcn.11.2.1747.1.


Environmental enrichment prevents Aβ oligomer-induced synaptic dysfunction through mirna-132 and hdac3 signaling pathways.

Wei Z, Meng X, El Fatimy R, Sun B, Mai D, Zhang J Neurobiol Dis. 2019; 134():104617.

PMID: 31669733 PMC: 7243177. DOI: 10.1016/j.nbd.2019.104617.


Hippocampal stem cells promotes synaptic resistance to the dysfunctional impact of amyloid beta oligomers via secreted exosomes.

Micci M, Krishnan B, Bishop E, Zhang W, Guptarak J, Grant A Mol Neurodegener. 2019; 14(1):25.

PMID: 31200742 PMC: 6570890. DOI: 10.1186/s13024-019-0322-8.


Differential MicroRNA Analyses of - and -Exposed hPBMCs Reveal Potential Biomarkers.

Cer R, Herrera-Galeano J, Frey K, Schully K, Luu T, Pesce J Int J Genomics. 2017; 2017:6489383.

PMID: 28791299 PMC: 5534298. DOI: 10.1155/2017/6489383.